Patents by Inventor William Crago

William Crago has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11919963
    Abstract: Provided herein are VHH-containing polypeptides that bind CD123. Uses of the VHH-containing polypeptides are also provided.
    Type: Grant
    Filed: August 1, 2022
    Date of Patent: March 5, 2024
    Assignee: Inhibrx, Inc.
    Inventors: Chelsie Macedo, Kyle Jones, William Crago, Andrew Hollands, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • Patent number: 11921116
    Abstract: The present disclosure relates to the use of one or more biomarkers to evaluate the likelihood that a CDK4 inhibitor would produce an anti-cancer effect in a subject. Accordingly, in certain non-limiting embodiments, the present disclosure provides for methods, compositions and kits for a companion diagnostic for CDK4 inhibitors, and in particular, for the use of the colocalization of Enigma and CDH18 biomarkers to foci within the cancer for determining whether the cancer can be successfully treated by CDK4 inhibition.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: March 5, 2024
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Mary Elizabeth Dooley, Marta Kovatcheva, Samuel Singer, William D. Tap, Aimee Crago, Andrew Koff
  • Publication number: 20230312716
    Abstract: Provided herein are VHH-containing polypeptides that bind CD33. Uses of the VHH-containing polypeptides are also provided.
    Type: Application
    Filed: December 16, 2022
    Publication date: October 5, 2023
    Applicant: Inhibrx, Inc.
    Inventors: Kyle S. Jones, William Crago, Angelica Sanabria, Andrew Hollands, Jacob Gano, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • Publication number: 20230128188
    Abstract: Provided herein are VHH-containing polypeptides that bind OX40. In some embodiments, VHH-containing polypeptides that bind and agonize OX40 are provided. Uses of the VHH-containing polypeptides are also provided.
    Type: Application
    Filed: August 8, 2022
    Publication date: April 27, 2023
    Applicant: Inhibrx, Inc.
    Inventors: John C. Timmer, William Crago, Kyle Jones, Katelyn Willis, Florian Sulzmaier, Bryan Becklund, Brendan P. Eckelman
  • Publication number: 20230065306
    Abstract: Provided herein are VHH-containing polypeptides that bind CD123. Uses of the VHH-containing polypeptides are also provided.
    Type: Application
    Filed: August 1, 2022
    Publication date: March 2, 2023
    Applicant: Inhibrx, Inc.
    Inventors: Chelsie Macedo, Kyle Jones, William Crago, Andrew Hollands, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • Patent number: 11560428
    Abstract: Provided herein are VHH-containing polypeptides that bind CD33. Uses of the VHH-containing polypeptides are also provided.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: January 24, 2023
    Assignee: Inhibrx, Inc.
    Inventors: Kyle S. Jones, William Crago, Angelica Sanabria, Andrew Hollands, Jacob Gano, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • Publication number: 20220324942
    Abstract: The present disclosure provides improved CD33 targeting polypeptides and compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith.
    Type: Application
    Filed: May 7, 2020
    Publication date: October 13, 2022
    Applicants: 2SEVENTY BIO, INC., INHIBRX, INC.
    Inventors: JORDAN JARJOUR, MARK POGSON, WAI-HANG LEUNG, KYLE JONES, WILLIAM CRAGO, ANGELICA SANABRIA, ANDREW HOLLANDS, JACOB GANO, MILTON MA, JOHN C. TIMMER, BRENDAN P. ECKELMAN
  • Publication number: 20220315638
    Abstract: The present disclosure provides improved CD123 targeting polypeptides and compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith.
    Type: Application
    Filed: May 7, 2020
    Publication date: October 6, 2022
    Applicants: 2SEVENTY BIO, INC., INHIBRX, INC.
    Inventors: JORDAN JARJOUR, MARK POGSON, WAI-HANG LEUNG, CHELSIE MACEDO, KYLE JONES, WILLIAM CRAGO, ANDREW HOLLANDS, MILTON MA, JOHN C. TIMMER, BRENDAN P. ECKELMAN
  • Patent number: 11447556
    Abstract: Provided herein are VHH-containing polypeptides that bind OX40. In some embodiments, VHH-containing polypeptides that bind and agonize OX40 are provided. Uses of the VHH-containing polypeptides are also provided.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: September 20, 2022
    Assignee: Inhibex, Inc.
    Inventors: John C. Timmer, William Crago, Kyle Jones, Katelyn Willis, Florian Sulzmaier, Bryan Becklund, Brendan P. Eckelman
  • Patent number: 11434297
    Abstract: Provided herein are VHH-containing polypeptides that bind CD123. Uses of the VHH-containing polypeptides are also provided.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: September 6, 2022
    Assignee: Inhibrx, Inc.
    Inventors: Chelsie Macedo, Kyle Jones, William Crago, Andrew Hollands, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • Publication number: 20200347133
    Abstract: Provided herein are VHH-containing polypeptides that bind CD33. Uses of the VHH-containing polypeptides are also provided.
    Type: Application
    Filed: May 1, 2020
    Publication date: November 5, 2020
    Applicant: Inhibrx, Inc.
    Inventors: Kyle S. Jones, William Crago, Angelica Sanabria, Andrew Hollands, Jacob Gano, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • Publication number: 20200347142
    Abstract: Provided herein are VHH-containing polypeptides that bind CD123. Uses of the VHH-containing polypeptides are also provided.
    Type: Application
    Filed: May 1, 2020
    Publication date: November 5, 2020
    Applicant: Inhibrx, Inc.
    Inventors: Chelsie Macedo, Kyle Jones, William Crago, Andrew Hollands, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • Publication number: 20200055946
    Abstract: Provided herein are VHH-containing polypeptides that bind OX40. In some embodiments, VHH-containing polypeptides that bind and agonize OX40 are provided. Uses of the VHH-containing polypeptides are also provided.
    Type: Application
    Filed: August 12, 2019
    Publication date: February 20, 2020
    Applicant: Inhibrx, Inc.
    Inventors: John C. Timmer, William Crago, Kyle Jones, Katelyn Willis, Florian Sulzmaier, Bryan Becklund, Brendan P. Eckelman
  • Publication number: 20070220038
    Abstract: A method of populating a location information database for use in providing a location-based service to a host device that is an endpoint of a logical connection between the host device and a network access server. The method comprises receiving from the host device over the logical connection a request for network access; assigning a logical identifier to the host device in response to the receiving; determining a physical location associated with the endpoint of the logical connection; creating an association between the logical identifier and the physical location; and storing the association in the location information database.
    Type: Application
    Filed: March 20, 2006
    Publication date: September 20, 2007
    Inventor: William Crago
  • Publication number: 20060229059
    Abstract: A network element for use in a network that provides voice-over-packet services to a plurality of communication devices, each of the communication devices being associated with a respective directory number. The network element comprises an interface connectable to a trunk group dedicated to emergency calls and a control entity. The control entity is operable to: receive an incoming call originated by one of the communication devices; determine the directory number associated with the communication device having originated the incoming call; and determine whether the incoming call is an emergency call. Responsive to the incoming call being an emergency call, the control entity obtains a routing key that had been stored in association with the directory number; and directs the incoming call and the obtained routing key via the interface towards a gateway, the gateway connecting the network element to a dedicated emergency network.
    Type: Application
    Filed: June 12, 2006
    Publication date: October 12, 2006
    Inventors: William Crago, Hakem Habib, Marie Berthe Wilkes, Bernard Brabant, Guy Caron
  • Publication number: 20060140360
    Abstract: A method for execution by an owner of a mailbox in a voice mail system. The method comprises using an access device to access a voicemail message contained in the mailbox and entering a command instrumental in causing the voicemail message to be forwarded over a telephone network to a conversion entity. At the conversion entity, an electronic representation of the voicemail message is created and then the electronic representation of the voicemail message is rendered accessible to the owner of the mailbox, e.g., by sending an email message to a predetermined address. In this way, electronic representations of voicemail messages in a mailbox can be accessed by the owner of the mailbox using a device of choice, not necessarily the access device used initially to enter the command. Also, this functionality is achieved while allowing the voice mail system to remain a legacy voice mail system.
    Type: Application
    Filed: November 30, 2005
    Publication date: June 29, 2006
    Inventors: William Crago, David Clark, David Johnston
  • Publication number: 20060078095
    Abstract: A method of routing an emergency call received at a network element. The method comprises determining a directory number associated with a communication device having originated the emergency call, consulting a local database to obtain routing information associated with the directory number, and directing the call and the routing information over a path dedicated to emergency calls. Also, a network element which comprises the database as well as a control entity, the control entity being operative for receiving an incoming call originated by one of the communication devices, determining the directory number associated with the communication device having originated the call, determining whether the call is an emergency call and, responsive to the call being an emergency call, accessing the database to obtain the routing information related to the directory number and directing the call as well as the routing information over a trunk group dedicated to emergency calls.
    Type: Application
    Filed: November 12, 2004
    Publication date: April 13, 2006
    Inventors: William Crago, Hakem Habib, Marie Wilkes, Bernard Brabant, Guy Caron
  • Publication number: 20060077961
    Abstract: The delivery of emergency services to users of a set of communication devices in a packet-switched network is enabled by a method that determines a routing key corresponding to a particular directory number that is associated with a particular communication device, and stores the directory number and the corresponding routing key in a database accessible to a packet switch. The steps of determining and storing are executed during a provisioning phase, in the absence of an emergency call placed by the communication device. The routing key is indicative of routing instructions to be followed by the packet switch upon receipt of a future emergency call placed by the communication device. When the call is received by the packet switch, it will consult the database to obtain the routing key associated with the directory number and send the call as well as the routing key over a path dedicated to emergency calls.
    Type: Application
    Filed: November 12, 2004
    Publication date: April 13, 2006
    Inventors: William Crago, Hakem Habib, Marie Wilkes, Bernard Brabant, Guy Caron
  • Publication number: 20050234829
    Abstract: A method and system for controlling distribution of content through a communications network uses a second, parallel network for delivery of a transaction indicia to a requesting party. The use of the parallel network enables the transaction indicia to be forwarded to the party independently of the communications network, thereby reducing the probability of a party fraudulently obtaining delivery of the content. Additionally, information associated with the parallel network can be used to restrict distribution of the content to parties within a predetermined domain, such as, for example, a geographical region. The content may be delivered to the party in an encrypted form, preferably using an encryption algorithm and key designed to enable decryption of the content on only the content delivery device from which the request for the content was originated.
    Type: Application
    Filed: June 10, 2005
    Publication date: October 20, 2005
    Applicant: Bell Canada
    Inventors: L. Williams, Alexander Markman, David Johnston, William Crago